Zobrazeno 1 - 10
of 44
pro vyhledávání: '"NAUNIHAL VIRDI"'
Autor:
Eden Miller, Gregory J. Roberts, Jennifer M. Joseph, Yelena Nabutovsky, Ignacio J. Reyes, Diana Souto, Naunihal Virdi, Irl B. Hirsch
Publikováno v:
American Journal of Medicine Open, Vol 9, Iss , Pp 100008- (2023)
Objectives: We compared clinical outcomes after acquiring a FreeStyle Libre© Flash Continuous Glucose Monitoring System (FSL) or Dexcom (DEX) continuous glucose monitoring (CGM) device in individuals with type 1 diabetes (T1D) and type 2 diabetes (T
Externí odkaz:
https://doaj.org/article/8bd4d03096944023adf5ed5fefc72cf7
Publikováno v:
Diabetes. 71
The discordance between the amount of new therapies for Type 2 diabetes (T2D) and improved outcomes highlights an unmet need for tools to help primary care providers (PCPs) make appropriate therapy adjustments. Here we present a novel CGM-based Gluco
Publikováno v:
Diabetes. 71
Background: HbA1c has traditionally been the gold standard of glycemic control. Continuous glucose monitoring (CGM) has enabled capture of newer glycemic measures such as time in range (TIR) which has been associated with diabetes outcomes, captures
Autor:
Naunihal Virdi, Yelena Nabutovsky, Irl B. Hirsch, Gregory J. Roberts, Jennifer Joseph, Eden Miller
Publikováno v:
Diabetes. 70
Continuous glucose monitor (CGM) use in diabetes is associated with improved clinical outcomes. However, evidence is lacking on whether changes in outcomes differ by CGM type. We compared clinical events between FreeStyle Libre and Dexcom recipients.
Publikováno v:
Diabetes. 70
Despite evidence pointing to clinical benefits of CGM, access has been limited by many state Medicaid plans. We assessed the budget impact of providing flash CGM to members with type 1 (T1D) or type 2 diabetes (T2D) taking multiple daily injections o
Autor:
Jennifer Joseph, Yelena Nabutovsky, Naunihal Virdi, Ignacio J. Reyes, Irl B. Hirsch, Eden Miller
Publikováno v:
Diabetes. 70
Continuous glucose monitor (CGM) use in diabetes is associated with improved clinical outcomes. However, evidence is lacking on whether changes in outcomes differ by CGM type. We compared A1c changes between FreeStyle Libre and Dexcom recipients. We
Publikováno v:
Journal of Diabetes Science and Technology
Autor:
Naunihal Virdi
Publikováno v:
Endocrine Practice. 27:1062
Publikováno v:
Diabetes Technology & Therapeutics. 23:S-36
Objective: We assessed the economic impact of using the newest flash continuous glucose monitoring (CGM) among Medicaid beneficiaries with diabetes treated with intensive insulin therapy (IIT). Res...
Publikováno v:
Diabetes. 68
Prior analyses of global data from real world use of flash glucose monitoring have associated frequency of scanning with greater time in range and lower mean glucose, glucose variability, and hypoglycemia. These analyses did not include data from Nor